Oral apolipoprotein A-I mimetic peptide improves cognitive function and reduces amyloid burden in a mouse model of Alzheimer’s disease

Recent evidence indicates that inflammation may significantly contribute to the pathogenesis of Alzheimer’s disease (AD). Since the apo A-I mimetic peptide D-4F has been shown to inhibit atherosclerotic lesion formation and regress already existing lesions (in the presence of pravastatin) and the pe...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Neurobiol Dis
Asıl Yazarlar: Handattu, Shaila P., Garber, David W., Monroe, Candyce E., van Groen, Thomas, Kadish, Inga, Nayyar, Gaurav, Cao, Dongfeng, Palgunachari, Mayakonda N., Li, Ling, Anantharamaiah, G.M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC5558244/
https://ncbi.nlm.nih.gov/pubmed/19344763
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nbd.2009.03.007
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller